date,title,source
Oct-31-18,Voyager Therapeutics to Host Third Quarter 2018 Financial Results and Corporate Highlights Conference Call,GlobeNewswire
Nov-07-18,Voyager Therapeutics: 3Q Earnings Snapshot,Associated Press
Nov-07-18,Voyager Therapeutics Announces Third Quarter 2018 Financial Results and Corporate Highlights,GlobeNewswire
Nov-07-18,Voyager Therapeutics Announces Positive Longer-Term Data for VY-AADC for Parkinsons Disease,GlobeNewswire
Nov-08-18,Edited Transcript of VYGR earnings conference call or presentation 7-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-08-18,"The Daily Biotech Pulse: Nantkwest Reports Positive Cancer Vaccine Trial Results, Sarepta Offering",Benzinga
Nov-19-18,Edited Transcript of VYGR earnings conference call or presentation 7-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-19-18,Voyager Therapeutics to Present at the Evercore ISI Healthcare Conference,GlobeNewswire
Nov-20-18,Edited Transcript of VYGR earnings conference call or presentation 7-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-23-18,"Report: Exploring Fundamental Drivers Behind Graphic Packaging Holding, QEP Resources, Inogen, CytRx, Voyager Therapeutics, and Daily Journal Corp. (S.C.)  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Nov-29-18,Voyager Therapeutics Enters into Strategic Manufacturing Collaborations with Brammer Bio and Fujifilm Diosynth Biotechnologies,GlobeNewswire
Dec-10-18,"Voyager Therapeutics Announces First Patient Dosed in RESTORE-1, a Phase 2 Trial of VY-AADC Gene Therapy for the Treatment of Parkinsons Disease",GlobeNewswire
Dec-17-18,Voyager Therapeutics Joins Michael J. Fox Foundation Initiatives and Education Campaigns to Accelerate the Development of New therapies and a Cure for Parkinsons Disease,GlobeNewswire
Jan-07-19,Voyager Therapeutics Provides Updates for VY-AADC Clinical Program for Parkinsons Disease,GlobeNewswire
Jan-15-19,"Voyager Therapeutics to Appoint Omar Khwaja, M.D., Ph.D., as Chief Medical Officer",GlobeNewswire
Jan-16-19,"Consolidated Research: 2019 Summary Expectations for Southern, Exelon, PriceSmart, Five Prime Therapeutics, Digi International, and Voyager Therapeutics  Fundamental Analysis, Key Performance Indications",GlobeNewswire
Jan-29-19,Here's Why Voyager Therapeutics Stock Soared as Much as 62.9% Today,Motley Fool
Jan-29-19,Neurocrine Biosciences and Voyager Therapeutics Form Strategic Development and Commercialization Collaboration for Parkinsons Disease and Friedreichs Ataxia,GlobeNewswire
Jan-30-19,Today's Research Reports on Trending Tickers: Voyager Therapeutics and Conatus Pharmaceuticals,ACCESSWIRE
Jan-31-19,Here are Boston-area biotechs pursuing Parkinson's treatments,American City Business Journals
Feb-01-19,German firm that serves gene therapy biotechs opens Cambridge HQ,American City Business Journals
Feb-04-19,Dr. Reddy's (RDY) Earnings and Revenues Improve Y/Y in Q3,Zacks
Feb-05-19,Neurocrine Biosciences Inc (NBIX) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Feb-13-19,Voyager Launches Highly Anticipated Retail Mobile App for Commission-Free Crypto Asset Trading,Business Wire
Feb-19-19,Voyager Therapeutics to Present at Upcoming Investor Conferences,GlobeNewswire
Feb-22-19,Watch These Four Biotech Stocks Friday,ACCESSWIRE
Feb-22-19,Why Voyager Therapeutics Is Skyrocketing Today,Motley Fool
Feb-22-19,Voyager Therapeutics stock jumps on 2nd Parkinson's deal,American City Business Journals
Feb-22-19,Voyager Shares Take Off on Parkinson's Disease Development Deal,TheStreet.com
Feb-22-19,Voyager Therapeutics stock soars after AbbVie collaboration potentially valued at over $1 billion,MarketWatch
Feb-22-19,Voyager Therapeutics and AbbVie Announce Collaboration to Develop Vectorized Antibodies to Treat Parkinsons Disease and Other Synucleinopathies,GlobeNewswire
Feb-22-19,AbbVie and Voyager Therapeutics Announce Collaboration to Develop Vectorized Antibodies to Treat Parkinson's Disease and Other Synucleinopathies,PR Newswire
Feb-25-19,AbbVie Extends Deal With Voyager to Make Parkinson's Drugs,Zacks
Feb-26-19,"Voyager Therapeutics, Inc. (VYGR) Q4 2018 Earnings Conference Call Transcript",Motley Fool
Feb-26-19,Voyager Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Corporate Highlights,GlobeNewswire
Feb-27-19,Edited Transcript of VYGR earnings conference call or presentation 26-Feb-19 9:30pm GMT,Thomson Reuters StreetEvents
